EMPLOYMENT AGREEMENTEmployment Agreement • November 4th, 2016 • Therapix Biosciences Ltd. • Pharmaceutical preparations
This Employment Agreement (this “Agreement”) is made and entered into on this 15 day of February 2016, by and between Therapix Biosciences Ltd., a public company organized under the laws of the State of Israel (the “Company”) and Elran Haber, Israeli I.D No. 040092702 residing at 23 Pinhas Eylon St., Holon, Israel (the “Employee”. The Company and Employee shall be sometimes referred to each as a “Party” and collectively as the “Parties”).
Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the “Commission”)** LICENSE AGREEMENTLicense Agreement • November 4th, 2016 • Therapix Biosciences Ltd. • Pharmaceutical preparations
This License Agreement (the "Agreement"), dated as of May 20, 2015 by and between Dekel Pharmaceuticals Ltd., corporate number 51-419250-9, a private company incorporated under the laws of Israel (the “Licensor”), and Therapix Biosciences Ltd., company number 51-358165-2, a public company whose shares are listed for trading on the Tel Aviv Stock Exchange ("TASE" and collectively, the “Licensee”). Licensee, on the one hand, and Licensor, on the other, may each individually be referred to in this Agreement as a “Party” and collectively referred to in this Agreement as the “Parties”.
Financial Services AgreementFinancial Services Agreement • November 4th, 2016 • Therapix Biosciences Ltd. • Pharmaceutical preparations • Tel-Aviv
This agreement (the “Agreement”) is entered into as of this __ day of November 2015 (the "Effective Date") between Therapix Biosciences Ltd. with principal offices at 5 Azrieli Center, 27th floor, Tel-Aviv 67025, Israel and its subsidiaries (the "Company") and Mr. Guy Goldin, licensed CPA, ID no. 029410768, of Klauzner 3th St. Ramat-Gan (“Contractor”).
RESEARCH FUNDING AND LICENSE AGREEMENTResearch Funding and License Agreement • November 4th, 2016 • Therapix Biosciences Ltd. • Pharmaceutical preparations
This Research Funding and License Agreement is entered into as of this 31st day of January, 2016 (the “Effective Date”), by and between Therapix BioSciences Ltd., a company formed under the laws of Israel, having a place of business at 5 Azrieli Center (Square Tower), Tel Aviv 6702501 Israel (the “Company”) and Ramot at Tel Aviv University Ltd. having a place of business at Tel-Aviv University, Ramat Aviv, Tel Aviv 6139201, Israel (“Ramot”). Ramot and the Company shall each be referred to in this Agreement as a “Party” and together as the “Parties”.
Consulting and Services AgreementConsulting and Services Agreement • November 4th, 2016 • Therapix Biosciences Ltd. • Pharmaceutical preparations • Tel-Aviv
This agreement (the “Agreement”) is entered into as of this 16 day of February 2016 (the "Effective Date") between Therapix Biosciences Ltd. with principal offices at 5 Azrieli Center, 27th floor, Tel-Aviv 67025, Israel and its subsidiaries (the "Company") and Dr. Ascher Shmulewitz, of __________ (“Dr. Shmulewitz”).
CONSULTING AGREEMENTConsulting Agreement • November 4th, 2016 • Therapix Biosciences Ltd. • Pharmaceutical preparations
THIS CONSULTING AGREEMENT (this "Agreement") is made as of this 29 day of November (the "Effective Date"), by and between Therapix Biosciences Ltd., a company organized under the laws of the State of Israel (the "Company") with registered address at Azrieli Center, 27th floor, Tel-Aviv 67025, Israel, and Doron Ben-Ami ,ID no. 57690653 (the "Consultant"). The Company and the Consultant shall sometimes be referred to, each as a "Party" and collectively, as the "Parties".
